A prospective, randomised, partially-blinded, placebo-controlled, phase III, multicentre trial to assess safety, tolerability and imunogenicity of liquid influenza virus vaccine, trivalent, types A & B, live cold-adapted (liquid CAIV-T) administered concomitantly with live, attenuated, poliovirus vaccine in healthy children

Simple item page
dc.contributor.authorBreiman, Robert F.
dc.contributor.authorBrooks, Abdullah
dc.contributor.authorNaheed, Aliya
dc.date.accessioned2014-02-19T09:00:17Z
dc.date.available2014-02-19T09:00:17Z
dc.date.issued2001
dc.identifier.otherhttp://dspace.icddrb.org/jspui/handle/123456789/4924
dc.identifier.urihttp://hdl.handle.net/123456789/4924
dc.language.isoen
dc.sourceICDDR,B Institutional Repository
dc.subjectClinical Protocols
dc.subjectVaccination
dc.subjectChild
dc.subjectProspective Studies
dc.titleA prospective, randomised, partially-blinded, placebo-controlled, phase III, multicentre trial to assess safety, tolerability and imunogenicity of liquid influenza virus vaccine, trivalent, types A & B, live cold-adapted (liquid CAIV-T) administered concomitantly with live, attenuated, poliovirus vaccine in healthy children
dc.typeOther

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
ICDDRBProtocol-2001-011.pdf
Size:
1.9 MB
Format:
Adobe Portable Document Format
Download

Collections

Public health sciences research protocols